Hologic Inc (HOLX)
Hologic Inc. (HOLX) is a global healthcare company specializing in medical technology, diagnostic products, and surgical interventions. The company primarily focuses on women's health, offering products for breast health, gynecology, and skeletal health, as well as diagnostic solutions in molecular and reproductive health. Established in 1985, Hologic is known for innovative products that enhance early detection, diagnosis, and treatment of various health conditions.
Company News
Hologic will be acquired by funds managed by Blackstone and TPG for $18.3 billion, with a purchase price of $79 per share representing a 46% premium. The transaction is expected to close in the first half of 2026.
Women's Health Collective Canada launched Vital Talks, a national online seminar series focusing on women's health, starting with a menopause care event supported by multiple healthcare and research partners.
Baxter International Inc. reported better-than-expected Q2 2024 earnings, with adjusted EPS of 68 cents beating the consensus estimate. Revenue also topped expectations, driven by growth across the company's business segments. The company provided positive guidance for Q3 and full-year 2024.
A group of 100 next-generation Nasdaq-traded names, including sports-betting company DraftKings, appears poised to move higher, according to one Wall Street analyst.
